Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis: Victoria, British Columbia Thursday, November 14, 2024, ...
AstraZeneca India and Indian Academy of Paediatrics Unite to raise awareness on respiratory syncytial virus in India: Our Bureau, Bengaluru Thursday, November 14, 2024, 16:45 Hrs ...
Caliway’s drug molecule CBL-514 to treat Dercum’s disease receives EMA orphan drug designation: New Taipei City Thursday, November 14, 2024, 16:00 Hrs [IST] Caliway Biopharmac ...
Biocon Academy achieves 100% placement for its 6th batch and concludes 5th edition of MCADDI residential programme for industry: Our Bureau, Bengaluru Thursday, November 14, 2024, ...
As a significant milestone in India's pharma sector, the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26 to 28, 2024 ...
Survey shows unsustainable regulatory workloads leave no choice about AI adoption: Boston, Massachusetts Thursday, November 14, 2024, 17:00 Hrs [IST] ArisGlobal, an innovative tec ...
IDF research reveals diabetes impacts the mental well-being of over 4 in 5 Indians living with the condition: Our Bureau, Bengaluru Thursday, November 14, 2024, 15:45 Hrs [IST] In ...
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers: London, UK Thursday, November 14, 2024, 15:00 Hrs [IST] GSK plc announced t ...
Researchers uncover new role of mutant proteins in some of the deadliest cancers: Maryland Thursday, November 14, 2024, 13:00 Hrs [IST] Researchers at the National Institutes of H ...
Mississauga, Ontario Thursday, November 14, 2024, 09:00 Hrs [IST] ...
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
Pharma Programme, that the Pradhan Mantri Scholarship for Pharmacy Postgraduate Studies (PMSPPS) will be awarded to eligible ...